Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Revenue

Heidelberg Pharma AG had revenue of 4.07M EUR in the quarter ending February 28, 2026, with 220.19% growth. This brings the company's revenue in the last twelve months to 2.65M, down -68.64% year-over-year. In the fiscal year ending November 30, 2025, Heidelberg Pharma AG had annual revenue of 1.46M, down -78.72%.

• Revenue (ttm): 2.65M
• Revenue Growth: -68.64%
• P/S Ratio: 48.16
• Revenue / Employee: 23.89K
• Employees: 114
• Market Cap: 127.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2025	1.46M	-5.39M	-78.72%
Nov 30, 2024	6.85M	-3.01M	-30.53%
Nov 30, 2023	9.86M	-8.66M	-46.75%
Nov 30, 2022	18.51M	16.48M	810.30%
Nov 30, 2021	2.03M	-6.63M	-76.53%

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error